Annual Gross Profit
$8.93 M
+$230.00 K+2.65%
30 April 2024
Summary:
ImmunoPrecise Antibodies annual gross profit is currently $8.93 million, with the most recent change of +$230.00 thousand (+2.65%) on 30 April 2024. During the last 3 years, it has risen by +$108.20 thousand (+1.23%). IPA annual gross profit is now at all-time high.IPA Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$2.52 M
+$797.20 K+46.35%
31 October 2024
Summary:
ImmunoPrecise Antibodies quarterly gross profit is currently $2.52 million, with the most recent change of +$797.20 thousand (+46.35%) on 31 October 2024. Over the past year, it has increased by +$342.60 thousand (+15.75%). IPA quarterly gross profit is now -9.04% below its all-time high of $2.77 million, reached on 31 January 2021.IPA Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$8.89 M
+$342.60 K+4.01%
31 October 2024
Summary:
ImmunoPrecise Antibodies TTM gross profit is currently $8.89 million, with the most recent change of +$342.60 thousand (+4.01%) on 31 October 2024. Over the past year, it has dropped by -$35.10 thousand (-0.39%). IPA TTM gross profit is now -2.48% below its all-time high of $9.12 million, reached on 31 July 2021.IPA TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPA Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.6% | +15.8% | -0.4% |
| 3 y3 years | +1.2% | +22.9% | -1.8% |
| 5 y5 years | +122.1% | +33.8% | +96.7% |
IPA Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2.6% | -3.8% | +46.4% | -2.2% | +6.7% |
| 5 y | 5 years | at high | +122.1% | -9.0% | +77.9% | -2.5% | +96.7% |
| alltime | all time | at high | -9.0% | -2.5% |
ImmunoPrecise Antibodies Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | $2.52 M(+46.3%) | $8.89 M(+4.0%) |
| July 2024 | - | $1.72 M(-24.9%) | $8.55 M(-4.2%) |
| Apr 2024 | $8.93 M(+2.6%) | $2.29 M(-3.3%) | $8.92 M(-1.9%) |
| Jan 2024 | - | $2.37 M(+8.8%) | $9.10 M(+1.9%) |
| Oct 2023 | - | $2.17 M(+3.9%) | $8.93 M(+1.0%) |
| July 2023 | - | $2.09 M(-15.0%) | $8.84 M(+1.9%) |
| Apr 2023 | $8.70 M(-0.7%) | $2.46 M(+12.1%) | $8.67 M(-1.7%) |
| Jan 2023 | - | $2.20 M(+5.3%) | $8.83 M(+1.8%) |
| Oct 2022 | - | $2.09 M(+8.5%) | $8.67 M(+0.5%) |
| July 2022 | - | $1.92 M(-26.4%) | $8.63 M(-1.3%) |
| Apr 2022 | $8.75 M(-0.7%) | $2.62 M(+28.2%) | $8.74 M(+4.9%) |
| Jan 2022 | - | $2.04 M(-0.3%) | $8.33 M(-8.0%) |
| Oct 2021 | - | $2.05 M(+0.4%) | $9.06 M(-0.7%) |
| July 2021 | - | $2.04 M(-7.5%) | $9.12 M(+3.1%) |
| Apr 2021 | $8.82 M(+46.5%) | $2.20 M(-20.3%) | $8.84 M(+9.8%) |
| Jan 2021 | - | $2.77 M(+31.2%) | $8.05 M(+15.5%) |
| Oct 2020 | - | $2.11 M(+19.7%) | $6.97 M(+3.4%) |
| July 2020 | - | $1.76 M(+24.5%) | $6.75 M(+12.1%) |
| Apr 2020 | $6.02 M(+49.8%) | $1.41 M(-16.3%) | $6.02 M(+19.6%) |
| Jan 2020 | - | $1.69 M(-10.2%) | $5.04 M(+11.3%) |
| Oct 2019 | - | $1.88 M(+81.5%) | $4.52 M(+21.7%) |
| July 2019 | - | $1.04 M(+141.7%) | $3.72 M(-4.3%) |
| Apr 2019 | $4.02 M | $428.70 K(-63.6%) | $3.88 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | $1.18 M(+9.4%) | $4.03 M(+10.9%) |
| Oct 2018 | - | $1.08 M(-10.5%) | $3.64 M(+21.7%) |
| July 2018 | - | $1.20 M(+108.0%) | $2.99 M(+64.0%) |
| Apr 2018 | $1.92 M(+78.1%) | $577.90 K(-26.1%) | $1.82 M(+9.7%) |
| Jan 2018 | - | $781.90 K(+83.4%) | $1.66 M(+70.8%) |
| Oct 2017 | - | $426.30 K(+1107.6%) | $972.30 K(+78.1%) |
| July 2017 | - | $35.30 K(-91.5%) | $546.00 K(+6.9%) |
| Apr 2017 | $1.08 M(>+9900.0%) | $417.10 K(+345.6%) | $510.70 K(+445.6%) |
| Jan 2017 | - | $93.60 K(>+9900.0%) | $93.60 K(>+9900.0%) |
| Sept 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | - | - |
| Dec 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | - | - |
| Dec 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00 | - | - |
| June 2008 | - | $0.00 | $0.00 |
FAQ
- What is ImmunoPrecise Antibodies annual gross profit?
- What is the all time high annual gross profit for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual gross profit year-on-year change?
- What is ImmunoPrecise Antibodies quarterly gross profit?
- What is the all time high quarterly gross profit for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly gross profit year-on-year change?
- What is ImmunoPrecise Antibodies TTM gross profit?
- What is the all time high TTM gross profit for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies TTM gross profit year-on-year change?
What is ImmunoPrecise Antibodies annual gross profit?
The current annual gross profit of IPA is $8.93 M
What is the all time high annual gross profit for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual gross profit is $8.93 M
What is ImmunoPrecise Antibodies annual gross profit year-on-year change?
Over the past year, IPA annual gross profit has changed by +$230.00 K (+2.65%)
What is ImmunoPrecise Antibodies quarterly gross profit?
The current quarterly gross profit of IPA is $2.52 M
What is the all time high quarterly gross profit for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly gross profit is $2.77 M
What is ImmunoPrecise Antibodies quarterly gross profit year-on-year change?
Over the past year, IPA quarterly gross profit has changed by +$342.60 K (+15.75%)
What is ImmunoPrecise Antibodies TTM gross profit?
The current TTM gross profit of IPA is $8.89 M
What is the all time high TTM gross profit for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high TTM gross profit is $9.12 M
What is ImmunoPrecise Antibodies TTM gross profit year-on-year change?
Over the past year, IPA TTM gross profit has changed by -$35.10 K (-0.39%)